Jazz Pharmaceuticals
JAZZ
#1899
Rank
โ‚น926.37 B
Marketcap
โ‚น15,245
Share price
1.67%
Change (1 day)
46.88%
Change (1 year)

Revenue for Jazz Pharmaceuticals (JAZZ)

Revenue in 2025 (TTM): โ‚น359.76 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น373.52 Billion. In 2024 the company made a revenue of โ‚น349.06 Billion an increase over the revenue in the year 2023 that were of โ‚น319.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jazz Pharmaceuticals from 2005 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น359.76 B3.07%
2024 โ‚น349.06 B9.36%
2023 โ‚น319.19 B5.41%
2022 โ‚น302.81 B31.48%
2021 โ‚น230.30 B33.24%
2020 โ‚น172.85 B12.13%
2019 โ‚น154.15 B16.59%
2018 โ‚น132.21 B27.93%
2017 โ‚น103.35 B2.22%
2016 โ‚น101.11 B14.85%
2015 โ‚น88.03 B18.44%
2014 โ‚น74.33 B37.92%
2013 โ‚น53.89 B67.99%
2012 โ‚น32.08 B122.75%
2011 โ‚น14.40 B84.96%
2010 โ‚น7.78 B30.66%
2009 โ‚น5.96 B83.66%
2008 โ‚น3.24 B26.62%
2007 โ‚น2.56 B29%
2006 โ‚น1.98 B105.89%
2005 โ‚น0.96 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Endo International
ENDPQ
โ‚น180.70 B-51.62%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
โ‚น22.856 T 6,019.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.064 T 1,255.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
โ‚น1.507 T 303.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel